000 01189 a2200325 4500
005 20250517234841.0
264 0 _c20191218
008 201912s 0 0 eng d
022 _a1875-6417
024 7 _a10.2174/1573399814666180903162556
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRana, Divya
245 0 0 _aIs there a Role for Sodium Orthovanadate in the Treatment of Diabetes?
_h[electronic resource]
260 _bCurrent diabetes reviews
_c2019
300 _a284-287 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aClinical Trials as Topic
650 0 4 _aDiabetes Mellitus
_xdrug therapy
650 0 4 _aDisease Models, Animal
650 0 4 _aEnzyme Inhibitors
_xchemistry
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
_xchemistry
650 0 4 _aPhosphorylation
650 0 4 _aProtein Tyrosine Phosphatase, Non-Receptor Type 1
_xantagonists & inhibitors
650 0 4 _aVanadates
_xpharmacology
700 1 _aKumar, Anoop
773 0 _tCurrent diabetes reviews
_gvol. 15
_gno. 4
_gp. 284-287
856 4 0 _uhttps://doi.org/10.2174/1573399814666180903162556
_zAvailable from publisher's website
999 _c28800062
_d28800062